TCL Archive Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies. July 9, 2010
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive NIH Grants: R29 Awards No Longer Accepted After June; NIH To Increase R01s. December 5, 1997
TCL Archive DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial February 1, 1985
